Methods for treating inflammatory disorders

• US 20090177123A1
• Filed: 12/23/2008
• Published: 07/09/2009
• Est. Priority Date: 12/28/2007
• Status: Abandoned Application

• Current Assignee: Celleration, Inc. (Adynxx, Inc)
• Original Assignee: Celleration, Inc. (Adynxx, Inc)
• Inventors: Peterson, Michael T.
• Application Number:
  US12/317,710
• Publication Number:
  US 20090177123A1
• Time in Patent Office: Days
• US Class Current: 601/2
• CPC Class Codes: A61M 35/00 Devices for applying media, e.g. remedies, on the human body devices for handling toiletry or cosmetic substances A45D; absorbent pads, e.g. swabs, A61F13/15
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

The invention provides methods for treating inflammatory disorders by administering low frequency ultrasound energy to decrease the inflammatory response. Exemplary inflammatory disorders are rheumatoid disorders including, but not limited to, rheumatoid arthritis, juvenile arthritis, bursitis, gout, spondylitis, scleroderma, Still'"'"'s disease, and vasculitis.

Claims

1. A method of treating an inflammatory disorder in a patient in need thereof, comprising delivering low frequency ultrasound energy from a non-contact distance to effected tissue of the patient in need thereof, wherein said low frequency ultrasound energy penetrates skin overlying the effected tissue to provide a therapeutic effect to decrease one or more symptoms of the inflammatory disorder, and wherein the inflammatory disorder is a rheumatoid disorder.

2. The method of claim 1, wherein the rheumatoid disorder is selected from one or more of rheumatoid arthritis, juvenile arthritis, bursitis, spondylitis, gout, scleroderma, Still'"'"'s disease, or vasculitis.

10. The method of claim 1, wherein the effected tissue is selected from one or more of joints, tendons, ligaments, or blood vessels.

11. The method of claim 10, wherein the effected tissue is one or more joints.

13. The method of claim 1, wherein the low frequency ultrasound energy is delivered via a liquid spray, and the method comprises delivering the low frequency ultrasound energy and the liquid spray from a non-contact distance to effected tissue of the patient in need thereof to provide a therapeutic effect.

14. The method of claim 1, wherein the low frequency ultrasound energy is delivered in the absence of a liquid spray or coupling agent.

3. -9. (canceled)

12. (canceled)

15. -17. (canceled)

18. A method for reducing pain associated with a rheumatoid disorder in a patient in need thereof, comprising

providing a transducer which can emit low frequency ultrasonic energy;

delivery said low frequency ultrasonic energy to effected tissue of said patient;

wherein said ultrasonic energy is delivered from a non-contact distance between a vibrating tip of the transducer and said effected tissue of said patient, and wherein the delivered ultrasonic energy provides a therapeutic effect to reduce pain associated with said rheumatoid disorder.

19. The method of claim 18, wherein the effected tissue is selected from one or more of joints, tendons, and ligaments.

20. The method of claim 18, wherein the ultrasonic energy is delivered via a liquid spray, and the method comprises delivering the low frequency ultrasonic energy and the liquid spray to said patient.

21. The method of claim 20, wherein the liquid spray is generated by delivering liquid to a distal portion of the transducer.

22. The method of claim 18, wherein the ultrasonic energy is delivered in the absence of a liquid spray or coupling agent.

23. The method of claim 18, wherein the method is part of a therapeutic regimen combining one or more additional treatment modalities.

24. The method of claim 23, wherein the one or more additional treatment modalities comprises applying a topical medicament to the effected tissue or administering a systemic medicament prior to and/or following delivering said ultrasonic energy.

25. The method of claim 23, wherein the one or more additional treatment modalities comprises a dietary regimen, an exercise regimen, yoga, heat, cold, acupuncture, acupressure, oral or intravenous analgesics, anti-inflammatory agents, corticosteroids, or anti-TNFα

therapeutic agents.

26. The method of claim 18, wherein delivering ultrasonic energy comprises delivering ultrasonic energy for at least about 2 consecutive minutes.

27. The method of claim 18, wherein the method comprises delivering ultrasonic energy at least twice per week for at least two weeks.

28. The method of claim 18, wherein the rheumatoid disorder is selected from rheumatoid arthritis or juvenile arthritis.

29. The method of claim 18, wherein the rheumatoid disorder is selected from any of bursitis, spondylitis, gout, scleroderma, Still'"'"'s disease, and vasculitis.

30. A method for treating a rheumatoid disorder, comprising

providing a transducer which can emit low frequency ultrasonic energy;

delivering said ultrasonic energy to a patient in need thereof;

wherein said ultrasonic energy is delivered from a non-contact distance between a vibrating tip of the transducer and treated patient tissue, and wherein the delivered ultrasonic energy provides a therapeutic effect to decrease one or more symptoms of said rheumatoid disorder in said patient.

31. The method of claim 30, wherein the ultrasonic energy is delivered to at least one of said patient'"'"'s joints, ligaments, or tendons.

32. The method of claim 30, wherein the ultrasonic energy penetrates the patient tissue to provide a therapeutic effect.

33. The method of claim 30, wherein the ultrasonic energy is delivered via a liquid spray, and the method comprises delivering the low frequency ultrasonic energy and the liquid spray to the patient.

34. The method of claim 33, wherein the liquid spray is generated by delivering liquid to a distal portion of the transducer.

35. The method of claim 30, wherein the ultrasonic energy is delivered in the absence of a liquid spray or coupling agent.

36. The method of claim 30, wherein the method is part of a therapeutic regimen combining one or more additional treatment modalities.

37. The method of claim 36, wherein the one or more additional treatment modalities comprises applying a topical medicament to the treated tissue or systemically administering medicament prior to and/or following delivering said ultrasonic energy.

38. The method of claim 36, wherein the one or more additional treatment modalities comprises a dietary regimen, an exercise regimen, yoga, heat, cold, acupuncture, acupressure, oral or intravenous analgesics, anti-inflammatory agents, corticosteroids, or anti-TNFα

therapeutic agents.

39. The method of claim 30, wherein delivering ultrasonic energy comprises delivering ultrasonic energy for at least about 2 consecutive minutes.

40. The method of claim 30, wherein the method comprises delivering ultrasonic energy at least twice per week for at least two weeks.

41. The method of claim 30, wherein the one or more symptoms are selected from one or more of inflammation, pain, tingling, weakness, decreased grip strength, swelling, itchiness, burning, fever, and decreased range of motion.

42. The method of claim 30, 35, wherein the rheumatoid disorder is selected from rheumatoid arthritis or juvenile arthritis.

43. The method of claim 30, wherein the rheumatoid disorder is selected from any of bursitis, spondylitis, gout, scleroderma, Still'"'"'s disease, and vasculitis.

50. The method of claim 30, wherein the ultrasonic energy is delivered at a frequency of approximately 200 kHz to 400 kHz.

51. The method of claim 30, wherein the ultrasonic energy is delivered at a frequency of approximately 20 kHz to 200 kHz.

52. The method of claim 30, wherein the ultrasonic energy is delivered at a frequency of approximately 30-50 kHz.

53. The method of claim 30, wherein the ultrasonic energy is delivered at a frequency of approximately 40 kHz.

54. The method of claim 30, wherein the ultrasonic energy level provided to patient tissue is approximately 0.1-2.0 watts/cm².

55. The method of claim 30, wherein the ultrasonic energy level provided to patient tissue is approximately 0.1-1.0 watts/cm².

56. The method of claim 30, wherein the ultrasonic energy level provided to patient tissue is approximately 0.1-0.7 watts/cm².

57. The method of claim 30, wherein the ultrasonic energy is delivered with a liquid spray, and wherein the liquid spray is selected from a saline solution or other substantially inert liquid.

58. The method of claim 30, wherein the ultrasonic energy is delivered with a liquid spray, and wherein the liquid spray includes a therapeutic medicament.

44. A method for managing symptoms of a rheumatoid disorder, comprising

providing a transducer which can emit low frequency ultrasonic energy;

delivering said ultrasonic energy to a patient in need thereof for at least two consecutive minutes at least twice per week;

wherein said ultrasonic energy is delivered from a non-contact distance between a vibrating tip of the transducer and treated patient tissue, and wherein the delivered ultrasonic energy provides a therapeutic effect to treat one or more symptoms of said rheumatoid disorder.

45. A method for decreasing the number of painful or swollen joints in a patient suffering from a rheumatoid disorder, comprising

providing a transducer which can emit low frequency ultrasonic energy;

delivering said ultrasonic energy to said patient;

wherein said ultrasonic energy is delivered from a non-contact distance between a vibrating tip of the transducer and treated patient tissue, and wherein the delivered ultrasonic energy provides a therapeutic effect to decrease the number of painful or swollen joints in said patient.

46. A method for decreasing expression of an inflammatory cytokine in a patient having a rheumatoid disorder, comprising

providing a transducer which can emit low frequency ultrasonic energy;

delivering said ultrasonic energy to said patient in need thereof;

wherein the delivered ultrasonic energy decreases expression of said inflammatory cytokine in one or more of an effected joint, ligament, tendon, skin, or blood vessel of said patient, and wherein said inflammatory cytokine is TNFα

.

47. The method of claim 46, wherein the ultrasonic energy is delivered via a liquid spray, and the method comprises delivering the low frequency ultrasonic energy and the liquid spray to the patient.

48. The method of claim 47, wherein the liquid spray is generated by delivering liquid to a distal portion of the transducer.

49. The method of claim 46, wherein the ultrasonic energy is delivered in the absence of a liquid spray or coupling agent.